Blood thinner use at Life's end: a closer look

NCT ID NCT07338071

Not yet recruiting Knowledge-focused Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observes how often blood-thinning drugs are prescribed to patients receiving palliative care. Researchers will track 410 adults to understand current practices, since there are no clear guidelines. The goal is to gather information that could lead to better, more consistent care at the end of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: antithrombotic drugs
What this could lead to: If successful, this study could provide data to help develop guidelines for using blood thinners in end-of-life care, reducing variability in treatment.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly change patient care. Results may not apply to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PALLIATIVE CARE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Death

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PALLIATIVE CARE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, RM, 00168, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.